Adaptive Biotechnologies Corp Quarterly Interest Expense in USD from Q3 2022 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Adaptive Biotechnologies Corp quarterly/annual Interest Expense history and growth rate from Q3 2022 to Q3 2024.
  • Adaptive Biotechnologies Corp Interest Expense for the quarter ending September 30, 2024 was $2.94M, a 19.5% decline year-over-year.
  • Adaptive Biotechnologies Corp Interest Expense for the twelve months ending September 30, 2024 was $11.6M.
  • Adaptive Biotechnologies Corp annual Interest Expense for 2023 was $13.8M, a 226% increase from 2022.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $11.6M $2.94M -$713K -19.5% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $12.4M $2.7M -$909K -25.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $13.3M $2.99M -$538K -15.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $13.8M $3.01M Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 $3.65M +$3M +459% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $3.61M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 $3.53M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q3 2022 $653K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.